Surgical or Medical Treatment

NCT04128995 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2026-03-24

No results posted yet for this study

Summary

This study will test the hypothesis that metabolic bariatric surgery will be more effective at providing durable glycemic control and reduce co-morbidities than intensive medical therapy in youth with type 2 diabetes.

Conditions

  • Diabetes Mellitus, Type 2
  • Pediatric Obesity
  • Bariatric Surgery Candidate

Interventions

PROCEDURE

Advanced Medical Therapy and Bariatric Surgery

Vertical Sleeve Gastrectomy and Advanced Medical Therapy that could include metformin, GLP-1 agonist, SGLT-2 inhibitor, or basal insulin for youth with type 2 diabetes

DRUG

Advanced Medical Therapy

Advanced Medical Therapy that could include metformin, GLP-1 agonist, SGLT-2 inhibitor, or basal insulin for youth with type 2 diabetes

PROCEDURE

Bariatric Surgery

Vertical Sleeve Gastrectomy for youth without type 2 diabetes

Sponsors & Collaborators

  • Children's Hospital Colorado

    collaborator OTHER
  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Amy S Shah, MD MS · Cincinnati Childrens Hospital Medical Center

  • Kristen J Nadeau, MD MS · Children's Hospital Colorado

  • Michael A Helmrath, MD MS · Children's Hospital Medical Center, Cincinnati

  • Thomas H Inge, MD PhD · Ann & Robert H Lurie Children's Hospital of Chicago

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-15
Primary Completion
2026-12-31
Completion
2026-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04128995 on ClinicalTrials.gov